The current financial score of Rxsight Inc is 6.64. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 33.74M, representing a year-over-year increase of 0.31%, while its net profit experienced a year-over-year increase of 2.64%.
The current valuation score of Rxsight Inc is 8.09. Its current P/E ratio is -5.30, which is -23.75% below the recent high of -4.04 and -1174.64% above the recent low of -67.56.
The current earnings forecast score of Rxsight Inc is 5.80. The average price target is 8.04, with a high of 11.00 and a low of 6.30.
The current price momentum score of Rxsight Inc is 4.23. Currently, the stock price is trading between the resistance level at 7.05 and the support level at 5.39, making it suitable for range-bound swing trading.
The current institutional shareholding score of Rxsight Inc is 10.00. The latest institutional shareholding proportion is 93.24%, representing a quarter-over-quarter increase of 11.69%. The largest institutional shareholder is James Simons, holding a total of 140.69K shares, representing 0.00% of shares outstanding, with 94.59% decrease in holdings.
The current risk assessment score of Rxsight Inc is 4.93. The company's beta value is 1.17. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.